Application Nr Approved Date Route Status External Links
NDA208259 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1. Indications And Usage Rocklatan (Netarsudil And Latanoprost Ophthalmic Solution) 0.02%/0.005% Is A Fixed Dose Combination Of A Rho Kinase Inhibitor And A Prostaglandin F 2α Analogue Indicated For The Reduction Of Elevated Intraocular Pressure (Iop) In Patients With Open-Angle Glaucoma Or Ocular Hypertension. Rocklatan ® 0.02%/0.005% Is A Fixed Dose Combination Of A Rho Kinase Inhibitor And A Prostaglandin F 2α Analogue Indicated For The Reduction Of Elevated Intraocular Pressure (Iop) In Patients With Open-Angle Glaucoma Or Ocular Hypertension. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Latanoprost LATANOPROST ZINC12468792
2. Netarsudil Mesylate

Comments